The Board granted service connection for the cause of the Veteran's death, linking his chronic obstructive pulmonary disease to Agent Orange exposure during his military service in Vietnam.
The deciding factor: The weight of the competent medical evidence related the Veteran's COPD to his presumed Agent Orange exposure in service.
- Claimed conditions
- chronic obstructive pulmonary disease
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- January 13, 2022
- Citation
- 22001812
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted service connection for gastroesophageal reflux disease, obstructive sleep apnea, and chronic obstructive pulmonary disease but denied service connection for irritable bowel syndrome. The Board also denied an increased rating for the Veteran's service-connected psychiatric condition.
- Partly granted
The Board granted restoration of the 10 percent evaluation for left knee meniscus, effective April 21, 2025, and an additional 20 percent rating was also granted.
- Granted
The Board granted an increased (Level 2) stipend in the PCAFC for the Veteran's caregiver due to the need for continuous supervision and protection based on the Veteran's medical conditions.
- Remanded (sent back)
The Board remands the issues for further development and readjudication by the AOJ.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.